Genmab A (GMAB) Accumulated Depreciation & Amortization (2023 - 2025)

Genmab A (GMAB) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 45.45% year-over-year to $16.0 million, compared with a TTM value of $16.0 million through Dec 2025, up 45.45%, and an annual FY2025 reading of $16.0 million, up 45.45% over the prior year.
  • Accumulated Depreciation & Amortization was $16.0 million for Q4 2025 at Genmab A, up from $11.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $16.0 million in Q4 2025 and bottomed at $8.0 million in Q4 2023.
  • Average Accumulated Depreciation & Amortization over 3 years is $11.7 million, with a median of $11.0 million recorded in 2024.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 37.5% in 2024, then surged 45.45% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $8.0 million in 2023, then soared by 37.5% to $11.0 million in 2024, then soared by 45.45% to $16.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for GMAB at $16.0 million in Q4 2025, $11.0 million in Q4 2024, and $8.0 million in Q4 2023.